List of Eureka Therapeutics, Inc patents

List of Eureka Therapeutics, Inc patents

List of Insulet patents

List of Memory Pharmaceuticals patents

List of Alaxala Networks patents

List of funding rounds for Getir (grocery delivery company)

List of funding rounds for Genlith Inc.

Patents where

Current Assignee

Name

is

Eureka Therapeutics, Inc

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11421013 Antibody/T-cell receptor chimeric constructs and uses thereof	Patent 11421013 was granted and assigned to Eureka Therapeutics, Inc on August, 2022 by the United States Patent and Trademark Office.	Eureka Therapeutics, Inc	Eureka Therapeutics, Inc		United States Patent and Trademark Office	11421013	August 23, 2022
	‌ US Patent 10098951 Antibody/T-cell receptor chimeric constructs and uses thereof	Patent 10098951 was granted and assigned to Eureka Therapeutics, Inc on October, 2018 by the United States Patent and Trademark Office.	Eureka Therapeutics, Inc	Eureka Therapeutics, Inc		United States Patent and Trademark Office	10098951	October 16, 2018
	‌ US Patent 10464988 Antibody/T-cell receptor chimeric constructs and uses thereof	Patent 10464988 was granted and assigned to Eureka Therapeutics, Inc on November, 2019 by the United States Patent and Trademark Office.	Eureka Therapeutics, Inc	Eureka Therapeutics, Inc		United States Patent and Trademark Office	10464988	November 5, 2019
	‌ US Patent 10301388 Antibody agents specific for human CD19 and uses thereof	Patent 10301388 was granted and assigned to Eureka Therapeutics, Inc on May, 2019 by the United States Patent and Trademark Office.	Eureka Therapeutics, Inc	Eureka Therapeutics, Inc		United States Patent and Trademark Office	10301388	May 28, 2019
	‌ US Patent 10011658 Constructs targeting AFP peptide/MHC complexes and uses thereof	Patent 10011658 was granted and assigned to Eureka Therapeutics, Inc on July, 2018 by the United States Patent and Trademark Office.	Eureka Therapeutics, Inc	Eureka Therapeutics, Inc		United States Patent and Trademark Office	10011658	July 3, 2018
	‌ US Patent 11274157 Constructs targeting histone H3 peptide/MHC complexes and uses thereof		Eureka Therapeutics, Inc	Eureka Therapeutics, Inc		United States Patent and Trademark Office	11274157	March 15, 2022
	‌ US Patent 11447564 Constructs specifically recognizing glypican 3 and uses thereof		Eureka Therapeutics, Inc	Eureka Therapeutics, Inc		United States Patent and Trademark Office	11447564	September 20, 2022
	‌ US Patent 8025879 Modified glycoproteins and uses thereof	Patent 8025879 was granted and assigned to Eureka Therapeutics, Inc on September, 2011 by the United States Patent and Trademark Office.		Eureka Therapeutics, Inc		United States Patent and Trademark Office	8025879	September 27, 2011
	‌ US Patent 8080415 Modified host cells and uses thereof	Patent 8080415 was granted and assigned to Eureka Therapeutics, Inc on December, 2011 by the United States Patent and Trademark Office.		Eureka Therapeutics, Inc		United States Patent and Trademark Office	8080415	December 20, 2011
	‌ US Patent 10822389 Antibody/T-cell receptor chimeric constructs and uses thereof	Patent 10822389 was granted and assigned to Eureka Therapeutics, Inc on November, 2020 by the United States Patent and Trademark Office.	Eureka Therapeutics, Inc	Eureka Therapeutics, Inc		United States Patent and Trademark Office	10822389	November 3, 2020
	‌ US Patent 10822413 Cells expressing chimeric activating receptors and chimeric stimulating receptors and uses thereof	Patent 10822413 was granted and assigned to Eureka Therapeutics, Inc on November, 2020 by the United States Patent and Trademark Office.	Eureka Therapeutics, Inc	Eureka Therapeutics, Inc		United States Patent and Trademark Office	10822413	November 3, 2020
	‌ US Patent 8084222 Methods for generating host cells	Patent 8084222 was granted and assigned to Eureka Therapeutics, Inc on December, 2011 by the United States Patent and Trademark Office.		Eureka Therapeutics, Inc		United States Patent and Trademark Office	8084222	December 27, 2011
	‌ US Patent 11155615 Anti-ROR1 antibodies	Patent 11155615 was granted and assigned to Eureka Therapeutics, Inc on October, 2021 by the United States Patent and Trademark Office.		Eureka Therapeutics, Inc		United States Patent and Trademark Office	11155615	October 26, 2021
	‌ US Patent 11673957 Anti-ROR2 antibodies			Eureka Therapeutics, Inc		United States Patent and Trademark Office	11673957	June 13, 2023
	‌ US Patent 11993661 Constructs targeting prostate-specific membrane antigen (PSMA) and uses thereof	Patent 11993661 was granted and assigned to Eureka Therapeutics, Inc on May, 2024 by the United States Patent and Trademark Office.	Eureka Therapeutics, Inc	Eureka Therapeutics, Inc		United States Patent and Trademark Office	11993661	May 28, 2024
	‌ US Patent 11981742 Antibody agents specific for human CD19 and uses thereof	Patent 11981742 was granted and assigned to Eureka Therapeutics, Inc on May, 2024 by the United States Patent and Trademark Office.	Eureka Therapeutics, Inc	Eureka Therapeutics, Inc		United States Patent and Trademark Office	11981742	May 14, 2024
	‌ US Patent 11965021 Cells expressing chimeric activating receptors and chimeric stimulating receptors and uses thereof	Patent 11965021 was granted and assigned to Eureka Therapeutics, Inc on April, 2024 by the United States Patent and Trademark Office.	Eureka Therapeutics, Inc	Eureka Therapeutics, Inc		United States Patent and Trademark Office	11965021	April 23, 2024
	‌ US Patent 11976105 Antibody/T-cell receptor chimeric constructs and uses thereof	Patent 11976105 was granted and assigned to Eureka Therapeutics, Inc on May, 2024 by the United States Patent and Trademark Office.	Eureka Therapeutics, Inc	Eureka Therapeutics, Inc		United States Patent and Trademark Office	11976105	May 7, 2024

18 results

0 selected

18 results

0 selected